The Epoch Times
The Epoch Times
Focus

nirmatrelvir–ritonavir

COVID-19
COVID-19
|
Yuhong Dong

9 Things You Need to Know About Paxlovid

Feb 09, 2023
|
Yuhong Dong
Copy
Facebook
X
Truth
Gettr
LinkedIn
Telegram
Email
9 Things You Need to Know About Paxlovid
Feb 09
|
Copy
Facebook
X
Truth
Gettr
LinkedIn
Telegram
Email
Research & Discoveries
Research & Discoveries
|
Liane Lau

Hong Kong Study of Oral Antivirals Shows Promise for Omicron Patients

Oct 11, 2022
|
Liane Lau
Copy
Facebook
X
Truth
Gettr
LinkedIn
Telegram
Email
Hong Kong Study of Oral Antivirals Shows Promise for Omicron Patients
Oct 11
|
Copy
Facebook
X
Truth
Gettr
LinkedIn
Telegram
Email
COVID-19
COVID-19
|
Yuhong Dong

9 Things You Need to Know About Paxlovid

Feb 09, 2023
|
Yuhong Dong
Copy
Facebook
X
Truth
Gettr
LinkedIn
Telegram
Email
9 Things You Need to Know About Paxlovid
Feb 09
|
Copy
Facebook
X
Truth
Gettr
LinkedIn
Telegram
Email
Research & Discoveries
Research & Discoveries
|
Liane Lau

Hong Kong Study of Oral Antivirals Shows Promise for Omicron Patients

Oct 11, 2022
|
Liane Lau
Copy
Facebook
X
Truth
Gettr
LinkedIn
Telegram
Email
Hong Kong Study of Oral Antivirals Shows Promise for Omicron Patients
Oct 11
|
Copy
Facebook
X
Truth
Gettr
LinkedIn
Telegram
Email
home-iconepochtv-iconhealth-iconbright-iconepochfun-icon
The Epoch Times
To ensure we reach the high standards of reliability and neutrality that you expect from us, we are engaging with Ad Fontes Media to analyze our content. If you find an article you think falls short of the standard, please submit the link through this form.
Copyright © 2000 - 2025 The Epoch Times Association Inc. All Rights Reserved.